Regenicin Stock Price Prediction
| RGIN Stock | USD 0.0003 0.00 0.00% |
Momentum 57
Buy Extended
Oversold | Overbought |
Using Regenicin hype-based prediction, you can estimate the value of Regenicin from the perspective of Regenicin response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Regenicin to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Regenicin because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Regenicin after-hype prediction price | USD 2.31E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Regenicin |
Regenicin After-Hype Price Density Analysis
As far as predicting the price of Regenicin at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Regenicin or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Regenicin, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Regenicin Estimiated After-Hype Price Volatility
In the context of predicting Regenicin's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Regenicin's historical news coverage. Regenicin's after-hype downside and upside margins for the prediction period are 0.00 and 23.21, respectively. We have considered Regenicin's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Regenicin is out of control at this time. Analysis and calculation of next after-hype price of Regenicin is based on 3 months time horizon.
Regenicin Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Regenicin is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Regenicin backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Regenicin, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
3.39 | 23.40 | 0.04 | 0.00 | 3 Events / Month | 0 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0003 | 0.0002 | 23.09 |
|
Regenicin Hype Timeline
Regenicin is at this time traded for 0.0003. The entity has historical hype elasticity of 0.04, and average elasticity to hype of competition of 0.0. Regenicin is forecasted to decline in value after the next headline, with the price expected to drop to 2.31E-4. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -23.09%, whereas the daily expected return is at this time at 3.39%. The volatility of related hype on Regenicin is about 2127272.73%, with the expected price after the next announcement by competition of 0.00. About 18.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.0. Regenicin had not issued any dividends in recent years. The entity had 34:1 split on the 2nd of August 2010. Given the investment horizon of 90 days the next forecasted press release will be in about 3 days. Check out Regenicin Basic Forecasting Models to cross-verify your projections.Regenicin Related Hype Analysis
Having access to credible news sources related to Regenicin's direct competition is more important than ever and may enhance your ability to predict Regenicin's future price movements. Getting to know how Regenicin's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Regenicin may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| VOQP | VioQuest Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| QBIO | Q BioMed | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SCPS | Scopus Biopharma | 0.00 | 0 per month | 0.00 | 0.13 | 33.33 | (25.00) | 83.33 | |
| PARD | Poniard Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AOLS | Aeolus Pharmaceuticl | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| RCAR | RenovaCare | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OZYMF | Orphazyme AS | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NNLX | Nanologix | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VAXX | Vaxxinity | 0.01 | 3 per month | 121.64 | 0.31 | 14,900 | (99.00) | 15,000 | |
| XSNX | NovAccess Global | 0.00 | 0 per month | 0.00 | 0.13 | 0.00 | 0.00 | 400.00 |
Regenicin Additional Predictive Modules
Most predictive techniques to examine Regenicin price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Regenicin using various technical indicators. When you analyze Regenicin charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Regenicin Predictive Indicators
The successful prediction of Regenicin stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Regenicin, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Regenicin based on analysis of Regenicin hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Regenicin's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Regenicin's related companies.
Pair Trading with Regenicin
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Regenicin position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regenicin will appreciate offsetting losses from the drop in the long position's value.Moving together with Regenicin Pink Sheet
| 0.67 | VRTX | Vertex Pharmaceuticals Earnings Call This Week | PairCorr |
Moving against Regenicin Pink Sheet
| 0.68 | PBCRY | Bank Central Asia | PairCorr |
| 0.65 | ALNY | Alnylam Pharmaceuticals | PairCorr |
| 0.51 | ARGX | argenx NV ADR | PairCorr |
| 0.5 | PBCRF | PT Bank Central | PairCorr |
| 0.42 | BKRKF | PT Bank Rakyat | PairCorr |
The ability to find closely correlated positions to Regenicin could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Regenicin when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Regenicin - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Regenicin to buy it.
The correlation of Regenicin is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Regenicin moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Regenicin moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Regenicin can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Regenicin Pink Sheet
Regenicin financial ratios help investors to determine whether Regenicin Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Regenicin with respect to the benefits of owning Regenicin security.